Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia

Food and Healthcare Press Releases Thursday September 24, 2020 08:00
SEOUL South Korea--24 Sep--PRNewswire/InfoQuest
  • First-ever prefab on-site testing system for COVID-19 in Korea
  • Supply of all-in-one comprehensive mobile container-type COVID-19 testing system
  • Securing a bridgehead for global export by supplying to Indonesia
Macrogen has established the first "Smart Mobile Lab" in Korea and has supplied it to Indonesia as well.
Macrogen (CEO Sukang Lee,, a biotechnology company for precision medicine, announced that it established the first "Smart Mobile Lab (SML)" in Korea and exported it to Indonesia.

Macrogen signed its first export agreement with LG International, an affiliate of LG Group in Korea and a general trading company, on September 22nd. The initial two export units will be supplied to Indonesia through LG International. Following the first agreement, additional units are currently in last-minute negotiation over additional export agreements.

Macrogen's Smart Mobile Lab is the first-ever mobile container type for on-site COVID 19 testing developed in Korea. It offers one-stop COVID-19 testing within a matter of minutes and it can be easily installed wherever as necessary.

Macrogen has designed the SML that is easy to move and install in order to supply the K-quarantine packaging to overseas that are suffering from COVID-19 testing because of insufficient healthcare quarantine infrastructure. SML with strict Bio Safety Level-2(BSL-2) deals with all stages from viral RNA extraction, real-time polymerase chain reaction (RT-PCR), diagnosis, analysis, and to results. It also provides unique and differentiated services for Standard Operating Procedures (SOP), online/on-site training for lab technicians, and instrument maintenance.

Macrogen's SML also displays excellent performance in terms of sustainability as it can be extended into a process capable of molecular diagnostic testing for various infectious diseases other than COVID-19. Currently, Macrogen is in the course of preparation for related patent applications based on the unique design structure of SML and the implementation of differentiated additional features.

Sukang Lee, CEO of Macrogen said, "As a result of scrutinizing each country's response to COVID-19 after entering our new business field in molecular diagnostics this year, we determined that there was a limit to responding to COVID-19 pandemic by providing test kits, and thus we came up with the Smart Mobile Lab. This agreement with LG International is expected to contribute significantly towards expanding the scope of local medical systems in areas with insufficient disease control infrastructure and strengthening the capacity to respond to COVID-19 by introducing an excellent K-quarantine system."

"We will continue to cooperate closely with LG International to drive business performance in our new business sector, while also transparently sharing information and actively communicating with customers to enhance our corporate and shareholder value," CEO Lee emphasized.

LG International Corp.

LG International is an affiliate of LG Group and a general trading company established in 1953. Currently, it is engaged in various business projects with focus on energy, industrial goods, and solutions at 50 footholds in over 20 countries worldwide.


Macrogen is a precision medicine biotechnology company founded in 1997. It provides various services necessary for biotechnology and clinical research such as sequence analysis (CES and NGS), biochip analysis (Microarray), oligo synthesis (Oligo), genetically engineered mouse (GEM), and bioinformatics. Built on its know-how in the fields of clinical diagnosis and personal genomics, Macrogen has recently obtained the European CE-IVD certification for its COVID-19 testing kit and built Korea's first-ever "Smart Mobile Lab," an on-site prefab container-type COVID-19 testing system.

Macrogen Inc.
Photo -
Caption - Macrogen has established the first “Smart Mobile Lab” in Korea and has supplied it to Indonesia

Latest Press Release

CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate

- CStone to acquire exclusive rights for development and commercialization outside South Korea for LCB71, an ROR1 antibody drug conjugate - Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherapy and...

MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments

MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the CE Mark, launch and first human use of its Symani(R) Surgical System in Europe for open microsurgical procedures. The first...

BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures

M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 in the...

Boutique Corporation, RMUTL sign MOU to research and develop products for Thai traditional wellness based on hemp and cannabis

Bespoke Life Science Limited, a company under Boutique Corporation PCL, and Rajamangala University of Technology Lanna has signed the Memorandum of Understanding (MOU). The purpose of the MOU are to cooperate and to promote research and development,...

Annual SEA Mental Health Forum finds partnerships, innovation, and access as key solutions to tackling positive correlation between mental illness and COVID-19

- Mental health conditions such as schizophrenia, depression and neurological disorders are exacerbated by the COVID-19 pandemic across Southeast Asia markets - Utilization of telehealth and telepsychiatry, home delivery of medications, enhanced...

Related Topics